Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response

J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e896-e898. doi: 10.1111/jdv.17541. Epub 2021 Aug 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Dermatitis, Atopic* / drug therapy
  • Eczema*
  • Humans
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab